diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md
index c9eba7d7..abc2e200 100644
--- a/pages/STOP2030___Web___Posts.md
+++ b/pages/STOP2030___Web___Posts.md
@@ -9,6 +9,6 @@
 	  
 	  The general objectives of the REALISE study are to validate the benefits of the FDC through this pragmatic trial in a context of mass drug administration (MDA) programme to evaluate the safety as a primary endpoint and effectiveness profile as a secondary endpoint, in a large population of school-aged children.
 	  
-	  The clinical trial will have two arms, randomized by school. One will be administered a single dose of the fixed-dose coformulation tablet (), while the other, acting as an active control group, will receive a single dose of al
+	  The clinical trial will have two arms, randomized by school. One will be administered a single dose of the fixed-dose coformulation tablet (albendazole 400mg/ivermectin 9mg for 5-14 children, albendazole 400mg/ivermectin ), while the other, acting as an active control group, will receive a single dose of albendazole 400mg.
 	  
 	  #+END_VERSE
\ No newline at end of file